These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations. Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192 [TBL] [Abstract][Full Text] [Related]
7. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis. Grumach AS; Veronez CL; Csuka D; Farkas H Front Immunol; 2021; 12():785736. PubMed ID: 34956216 [TBL] [Abstract][Full Text] [Related]
8. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency. Jacobs J; Neeno T Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830 [TBL] [Abstract][Full Text] [Related]
9. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment. Magerl M; Germenis AE; Maas C; Maurer M Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting. Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373 [TBL] [Abstract][Full Text] [Related]
11. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. Mansi M; Zanichelli A; Coerezza A; Suffritti C; Wu MA; Vacchini R; Stieber C; Cichon S; Cicardi M J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353 [TBL] [Abstract][Full Text] [Related]
12. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency. Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232 [TBL] [Abstract][Full Text] [Related]
14. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype. Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108 [TBL] [Abstract][Full Text] [Related]
15. Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor. Jones DH; Bansal P; Bernstein JA; Fatteh S; Harper J; Hsu FI; O'Connor M; Park N; Suez D World Allergy Organ J; 2022 Jan; 15(1):100621. PubMed ID: 35145604 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema. Valerieva A; Caccia S; Cicardi M Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency. Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781 [TBL] [Abstract][Full Text] [Related]
18. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901 [TBL] [Abstract][Full Text] [Related]
19. Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study. Anderson J; Soteres D; Mellor J; Connolly H; Wynne-Cattanach K; Earl L; Schultz BG; Juethner S Allergy Asthma Proc; 2024 Jul; 45(4):247-254. PubMed ID: 38982603 [No Abstract] [Full Text] [Related]
20. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor. Bova M; Suffritti C; Bafunno V; Loffredo S; Cordisco G; Del Giacco S; De Pasquale TMA; Firinu D; Margaglione M; Montinaro V; Petraroli A; Radice A; Brussino L; Zanichelli A; Zoli A; Cicardi M Allergy; 2020 Jun; 75(6):1394-1403. PubMed ID: 31860755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]